Seeking Alpha

Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024

REDWOOD CITY, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (SEER) (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, will showcase the ...
Seeking Alpha

Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025

This featured session will highlight how multi-omic approaches powered by Seer’s Proteograph Product Suite are transforming translational genomics and clinical research. Brendan Keating, PhD, ...
Hosted on MSN

Seer, Inc. Earnings Call: Achievements Amid Challenges

Seer, Inc. ((SEER)) has held its Q3 earnings call. Read on for the main highlights of the call. The recent earnings call of Seer, Inc. painted a picture of both achievements and hurdles. The company ...
Business Insider

Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025

REDWOOD CITY, Calif., Oct. 10, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced its participation at the ...